Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

CRESCENT BIOPHARMA, INC. (CBIO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

CRESCENT BIOPHARMA, INC. (CBIO), most recent 12 months reported: revenue $10.84M, net loss $165.12M, free cash flow -$73.62M. Latest balance sheet on file: liquid cash $171.59M. From SEC filings. Others in Pharmaceutical Preparations: Keros Therapeutics, Inc. · Pyxis Oncology, Inc. · PALATIN TECHNOLOGIES, INC. · CV Sciences, Inc. · BIOAGE LABS, INC. · Evommune, Inc. · Zenas BioPharma, Inc. · Opus Genetics, Inc.

Stock screener

Watchlist